News | December 09, 2022
Emmes launches Cell and Gene Therapy Center
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
Total investment envisaged in this project stands at up to Rs 70 crore
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Subscribe To Our Newsletter & Stay Updated
